1. Amorim, Gustavo, Jaworski, James, Cordeiro-Santos, Marcelo, Sterling, Timothy R, Haas, David W. 2023. Pharmacogenetics of tuberculosis treatment toxicity and effectiveness in a large Brazilian cohort. In medRxiv : the preprint server for health sciences, , . doi:10.1101/2023.08.30.23294860. https://pubmed.ncbi.nlm.nih.gov/37693472/
2. Song, Qihan, Zhao, Fengli, Yao, Jingfan, Hu, Lei, Yu, Shun. 2020. Protective effect of microRNA-134-3p on multiple sclerosis through inhibiting PRSS57 and promotion of CD34+ cell proliferation in rats. In Journal of cellular biochemistry, 121, 4347-4363. doi:10.1002/jcb.29643. https://pubmed.ncbi.nlm.nih.gov/32619071/
3. Amorim, Gustavo, Jaworski, James, Yang, Jing, Sterling, Timothy R, Haas, David W. 2024. Pharmacogenetics of tuberculosis treatment toxicity and effectiveness in a large Brazilian cohort. In Pharmacogenetics and genomics, 35, 55-64. doi:10.1097/FPC.0000000000000552. https://pubmed.ncbi.nlm.nih.gov/39470346/
4. Lin, S Jack, Dong, Ken C, Eigenbrot, Charles, van Lookeren Campagne, Menno, Kirchhofer, Daniel. 2014. Structures of neutrophil serine protease 4 reveal an unusual mechanism of substrate recognition by a trypsin-fold protease. In Structure (London, England : 1993), 22, 1333-1340. doi:10.1016/j.str.2014.07.008. https://pubmed.ncbi.nlm.nih.gov/25156428/
5. AhYoung, Andrew P, Eckard, Sterling C, Gogineni, Alvin, Kirchhofer, Daniel, van Lookeren Campagne, Menno. 2020. Neutrophil serine protease 4 is required for mast cell-dependent vascular leakage. In Communications biology, 3, 687. doi:10.1038/s42003-020-01407-0. https://pubmed.ncbi.nlm.nih.gov/33214666/